Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing.


  • Publication date : 2016-01-29

Reference

Tourancheau A, Margaillan G, Rouleau M, Gilbert I, Villeneuve L, Lévesque E, Droit A, Guillemette C. Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing. Pharmacogenomics J. 2016;16:60-70. doi: 10.1038/tpj.2015.20. PubMed PMID: 25869014.

Additional information

Lien vers PubMed

Keywords

breast breast neoplasms endometrium female glucuronosyltransferase humans intestinal neoplasms intestines kidney kidney neoplasms liver liver neoplasms male metabolic detoxication, phase ii organ specificity prostate prostatic neoplasms rna, messenger sequence analysis, rna transcriptome uterine neoplasms

Abstract

Back